Evidence map›Paper›PMID 26190022›Full record

ArticleCellular and molecular life sciences : CMLS2015

Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.

Ellen Hubin, Stéphanie Deroo, Gabriele Kaminksi Schierle, Clemens Kaminski, Louise Serpell, Vinod Subramaniam, Nico van Nuland, Kerensa Broersen, Vincent Raussens, Rabia Sarroukh

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Communications chemistry · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Toxicity and Polymorphism of β-Amyloid Oligomers.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Single Point Mutation from E22-to-K in AOxidative medicine and cellular longevity · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ellen HubinNanobiophysics Group, Faculty of Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE, Enschede, The Netherlands.
Stéphanie DerooLaboratory of Structure and Function of Biological Membrane, Faculté des Sciences, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles (ULB), Campus de la Plaine CP 206/02, Boulevard du Triomphe, 1050, Brussels, Belgium.
Gabriele Kaminksi SchierleDepartment of Chemical Engineering and Biotechnology, University of Cambridge, New Museums Site, Pembroke Street, Cambridge, CB2 3RA, UK.
Clemens KaminskiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, New Museums Site, Pembroke Street, Cambridge, CB2 3RA, UK.
Louise SerpellSchool of Life Sciences, University of Sussex, Falmer, East Sussex, BN1 9QG, UK.
Vinod SubramaniamNanobiophysics Group, Faculty of Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE, Enschede, The Netherlands.
Nico van NulandStructural Biology Brussels, Department of Biotechnology (DBIT), Vrije Universiteit Brussel (VUB), Pleinlaan 2, 1050, Brussels, Belgium.
Kerensa BroersenNanobiophysics Group, Faculty of Science and Technology, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE, Enschede, The Netherlands. k.broersen@utwente.nl.
Vincent RaussensLaboratory of Structure and Function of Biological Membrane, Faculté des Sciences, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles (ULB), Campus de la Plaine CP 206/02, Boulevard du Triomphe, 1050, Brussels, Belgium.
Rabia SarroukhLaboratory of Structure and Function of Biological Membrane, Faculté des Sciences, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles (ULB), Campus de la Plaine CP 206/02, Boulevard du Triomphe, 1050, Brussels, Belgium. rsarrouk@ulb.ac.be.

Funding

Biotechnology and Biological Sciences Research Council BB/E009042/1Medical Research Council G0902243Medical Research Council MR/K02292X/1
6 · The paper itself

Abstract

Most Alzheimer's disease (AD) cases are late-onset and characterized by the aggregation and deposition of the amyloid-beta (Aβ) peptide in extracellular plaques in the brain. However, a few rare and hereditary Aβ mutations, such as the Italian Glu22-to-Lys (E22K) mutation, guarantee the development of early-onset familial AD. This type of AD is associated with a younger age at disease onset, increased β-amyloid accumulation, and Aβ deposition in cerebral blood vessel walls, giving rise to cerebral amyloid angiopathy (CAA). It remains largely unknown how the Italian mutation results in the clinical phenotype that is characteristic of CAA. We therefore investigated how this single point mutation may affect the aggregation of Aβ1-42 in vitro and structurally characterized the resulting fibrils using a biophysical approach. This paper reports that wild-type and Italian-mutant Aβ both form fibrils characterized by the cross-β architecture, but with distinct β-sheet organizations, resulting in differences in thioflavin T fluorescence and solvent accessibility. E22K Aβ1-42 oligomers and fibrils both display an antiparallel β-sheet structure, in comparison with the parallel β-sheet structure of wild-type fibrils, characteristic of most amyloid fibrils described in the literature. Moreover, we demonstrate structural plasticity for Italian-mutant Aβ fibrils in a pH-dependent manner, in terms of their underlying β-sheet arrangement. These findings are of interest in the ongoing debate that (1) antiparallel β-sheet structure might represent a signature for toxicity, which could explain the higher toxicity reported for the Italian mutant, and that (2) fibril polymorphism might underlie differences in disease pathology and clinical manifestation.

Indexed as

Alzheimer DiseaseAmino Acid SubstitutionAmyloidAmyloid beta-PeptidesGenetic Association StudiesHumansPhenotypePoint MutationProtein Structure, SecondaryAmyloidAmyloid beta-PeptidesAmyloid-beta peptideE22K mutationFibril polymorphismSecondary structureTropismβ-sheet conformation

Identifiers

PMID26190022
PMCPMC4648968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.